Similar Items: Comparing COVID-19 vaccine effectiveness in Türkiye: heterologous, inactivated, and mRNA vaccines
- Multi-epitope mRNA vaccine and protein vaccine protect mice against
- Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States
- The Time Course of Serum Iron and Serum Ferritin Concentrations Post-COVID-19 and Influenza Vaccinations
- Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review
- Association Between Race and COVID-19 Outcomes During the Pre-Vaccination Period in the United States (2020–2021)
- A Prospective Study of Immune Response After COVID-19 or Vaccination and Correlation Between Avidity Index and Neutralizing Capacity